Stock Price
173.29
Daily Change
-0.67 -0.39%
Monthly
2.00%
Yearly
19.91%
Q4 Forecast
170.05

EPS Reference Time Actual Consensus Previous
2026-11-23 FY2026Q4 PM 1.73 1.59
2026-08-26 FY2026Q3 PM 1.62 1.49 1.37
2026-05-27 FY2026Q2 PM 1.49 1.41 1.31
2026-02-25 FY2026Q1 PM 1.36 1.43 1.31
2025-11-24 FY2025Q4 PM 1.59 1.58 1.46



Peers Price Chg Day Year Date
Agilent 173.29 -0.67 -0.39% 19.91% Nov/16
Abbott 108.53 0.01 0.01% -16.53% Nov/16
Align Technology 166.95 -1.37 -0.81% 25.90% Nov/16
Bio-Rad Laboratories 364.07 -2.29 -0.63% 16.26% Nov/16
Bruker 61.08 -0.51 -0.83% 46.76% Nov/16
Charles River Laboratories 336.27 -1.70 -0.50% 106.63% Nov/16
Quest Diagnostics 261.69 2.09 0.81% 40.55% Nov/16
Danaher 232.25 -0.77 -0.33% 5.36% Nov/16
Edwards Lifesciences 106.94 -0.21 -0.20% 26.20% Nov/16
Henry Schein 84.96 -1.26 -1.46% 19.24% Nov/16

Indexes Price Day Year Date
US Index 500 7443 -118.59 -1.57% 11.55% Nov/16

Agilent traded at $173.58 this Monday November 16th, decreasing $0.38 or 0.22 percent since the previous trading session. Looking back, over the last four weeks, Agilent lost 2.17 percent. Over the last 12 months, its price rose by 20.11 percent. Looking ahead, we forecast Agilent to be priced at 170.05 by the end of this quarter and at 158.82 in one year, according to Trading Economics global macro models projections and analysts expectations.

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.